CLÆRITY®
is easy-to-use web-based software for investigation and management of potential safety
signals in adverse event data:
- Detect and investigate signals
- What are the significant signals for a drug, class, or group?
- Is the signal strength changing over time?
- Is the signal part of a bystander effect or a drug-drug interaction?
- How do safety profiles of similar drugs compare?
- Manage and monitor signal investigation workflow
- Classify signals of interest
- Track and monitor selected signals over time
- Document actions and decisions
- Generate summary status and detailed signal history reports
CLÆRITY Benefits
- Signal investigation for multiple SRS databases, including: FDA AERS, FDA
VAERS and Internal Company SRS Data
- Detect and investigate potential safety signals
- Manage and monitor signals of interest over time
- Document and track outstanding actions
- Use complementary data mining technologies (PVmaps®, PRR, MGPS) for full coverage
CLÆRITY Products and Services
- CLÆRITY License: ProSanos
offers flexible software licensing options to suit the specific safety information
needs of both large and small pharmaceutical companies.
- CLÆRITY-based service
- Ongoing surveillance, based on new releases of underlying SRS data sources
- In-depth, historical characterization of the safety profile of a drug or
drug class
- "Clean" version of AERS data, including drug name normalization
and mapping of obsolete MedDRA Terms
- Reference Event Database containing up-to-date literature references
found for a specific drug and/or adverse event
To see real case studies using
CLÆRITY, visit our PVmap of the Week
|
CLÆRITY is a next-generation drug safety software
product that can be used to investigate questions about the safety of a particular
drug, class of drugs, or therapeutic area.
For more information .
Related Links
|